AcronGenomics Inc.’s Business Associate Molecular Vision Ltd. Appoints Peter Woodford as Chairman

LONDON--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) is pleased to announce today that its business associate Molecular Vision Limited, an Imperial College London spin-out company developing quantitative point-of-care (POC) diagnostic devices, has appointed Peter Woodford as Non-Executive Chairman. The appointment serves to strengthen the board as Molecular Vision prepares to commercialise its novel detection technology, focusing on low cost POC diagnostic tests in a miniaturised, easy-to-use, disposable format.